Jefferies Group KROS Holdings History

Number of Shares
633,671.00
Current Holdings Value*
$41.95 Mil
% of Portfolio
0.4%
Total Estimate Gain
$-5.80 Mil
% of Total Estimate Gain
-15.61%

Jefferies Group's Keros Therapeutics Inc Holding Summary

As of 2024-03-31, Leucadia National held 633,671.00 shares of Keros Therapeutics Inc(KROS), totaling $41.95 Mil. This investment constitutes 0.4% of their stock portfolio, and Leucadia National now holds 1.76% of the outstanding Keros Therapeutics Inc(KROS) stock.

The initial trade took place in 2023Q4. And since then Jefferies Group has made 2 purchases of KROS, at an average price of $58.60, for a total of 633,671.00 shares. Based on historical transaction data and KROS's current price of $49.45, Jefferies Group's estimated gain on his KROS holdings is $-5.80 Mil, reflecting a -15.61% gain to date.

Jefferies Group KROS ($49.45) Holding Chart

Jefferies Group KROS ($49.45) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1